NCT03110003View on ClinicalTrials.gov

Bupivacaine With Epidural Volume Extension

PHASE3CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

June 27, 2016

Primary Completion Date

December 1, 2017

Study Completion Date

September 30, 2018

Conditions
Spinal AnesthesiaEpidural; Anesthesia
Interventions
DRUG

10 mg Bupivacaine

10 mg of preservative-free isobaric bupivacaine with 12.5mcg of fentanyl injected to the epidural space

DRUG

5 mg Bupivacaine

5 mg of preservative-free isobaric bupivacaine with 12.5mcg of fentanyl in combination with 10 mL of sterile saline injected into the epidural space.

Trial Locations (1)

35249

UAB Department of Anesthesiology and Perioperative Medicine, Birmingham

All Listed Sponsors
lead

University of Alabama at Birmingham

OTHER

NCT03110003 - Bupivacaine With Epidural Volume Extension | Biotech Hunter | Biotech Hunter